Analysts predict that Vascular Biogenics Ltd (NASDAQ:VBLT) will announce $180,000.00 in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Vascular Biogenics’ earnings, with the lowest sales estimate coming in at $70,000.00 and the highest estimate coming in at $280,000.00. Vascular Biogenics reported sales of $140,000.00 during the […]
